Immunotherapy for melanoma
Immunotherapy is one of the latest promising methods for melanoma treatment. It works successfully stimulating the body’s immune system in order to increase its ability to identify and kill cancer cells.
Prof. Schachter is a leading expert with many years of experience in immunotherapy for melanoma in Israel.
Prof. Jacob Schachter – Head of the Ella Lamelbaum Institute for Melanoma and Immunooncology at Sheba Academic Medical Center, Chaim Sheba Hospital, Israel.
Deputy Director of Oncology Department of Chaim Sheba Hospital.
Immune system protects the body from attacking infections caused by viruses and bacteria and abnormal cells of the human body (cancer) as well. Usually immune system is able to distinguish healthy normal cells from abnormal cells. But sometimes this mechanism does not work it cannot identify melanoma as dangerous cells.
Our oncologists use systemic immunotherapy in Israel for the treatment of metastatic cancer.
Medicines that were approved by FDA for melanoma immunotherapy:
♦ Ipilimumab (Yrvoy) – an antibody CTLA-4.
♦ Pembrolizumab (Keytruda) – an anti-PD-1.
♦ Nivolumab (Opdivo) – an anti-PD-1.
♦ Nivolumab (Opdivo) + Ipilimum (Yervoy) combination.
Other treatments for melanoma:
⇒ Microsurgical operation (Mohs Surgery)
We will contact you as soon as possible.
LDH analysis for melanoma treatment prognosis – study
A recent study, which appeared in the Journal of Clinical Oncology, may shed light on whether immunotherapy can really cure melanoma patients.
TIL therapy for melanoma
TIL (tumour-infiltrating lymphocytes) is one of the new modern kind of immunotherapy that used in Israel for the treatment of metastatic melanoma.